Skip to main content
Equibles

BARCLAYS PLC

Position in BTAIQ — BioXcel Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to BTAIQ Full portfolio

Position in BTAIQ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,013
+$1,999 QoQ
Shares Held
1,428
+17750.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 47 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAIQ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $488,035,802 across 62 Drug Manufacturers - Specialty & Generic names. BTAIQ ranks #51 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 2,302,737 $165,474,680
2 NBIX
Neurocrine Biosciences Inc
 324,807 $54,742,970
3 TEVA
Teva Pharmaceutical Industries Ltd
 1,343,554 $45,519,608
4 UTHR
UNITED THERAPEUTICS Corp
 72,010 $39,017,177
5 VTRS
Viatris Inc
 2,437,004 $38,699,622
6 INDV
Indivior Pharmaceuticals, Inc.
 907,024 $37,215,193
7 HIMS
Hims & Hers Health, Inc.
 861,006 $29,851,076
8 ALKS
Alkermes plc.
 219,935 $11,524,592

All Filings in BTAIQ

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,013 1,428
2024-12-31 — 88
2024-09-30 — 88
2024-06-30 — 137
2024-03-31 — 14,772
2023-12-31 — 27,895
2023-09-30 — 7,656
2023-06-30 — 100,720
2023-03-31 — 56,023
2022-12-31 — 5,136
2022-09-30 — 811
2022-06-30 — 2,437
2022-03-31 — 2,889
2021-12-31 — 20,929
2021-09-30 — 10,341
2021-06-30 — 5,912
2020-12-31 — 480
2020-09-30 — 28,487
2020-06-30 — 600